Q2 FY2026 · ended Jun 30, 2026 · Revenue $11.19M, -43.9% YoY · Filed Aug 14, 2026
Vaso Corporation (VASO) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $11.2 million and net income of $544,000. Free cash flow was $16.9 million. As of Jun 30, 2026 it held $38.3 million in cash and investments and $1.6 million in total debt.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- VASO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plainview, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 839087
- Former names
- VASOMEDICAL, INC (until Sep 23, 2016); VASOMEDICAL INC (until May 15, 2012)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $11.2M | $19.4M | $27.0M | $22.7M | $20.0M |
| Operating income | $974,000 | -$1.3M | -$2.8M | $1.5M | $93,000 |
| Net income | $544,000 | -$887,000 | $1.1M | $1.7M | -$197,000 |
| Diluted EPS | $0.00 | -$0.01 | $0.01 | $0.01 | $0.00 |
| Operating cash flow | $17.4M | -$12.6M | $261,000 | $2.8M | $6.8M |
| Free cash flow | $16.9M | -$13.1M | — | — | — |
| Total assets | $85.9M | $83.0M | $88.3M | $84.5M | $82.6M |
| Stockholders' equity | $29.2M | $28.6M | $29.4M | $28.2M | $26.5M |
| Cash and investments | $38.3M | — | $34.1M | $34.9M | $32.6M |
| Total debt | $1.6M | $2.1M | $1.5M | $1.8M | $2.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K/A | Amended current report | Aug 6, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 23, 2026 | Jul 23, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
May 8, 2026 | May 4, 2026 |
All 508 Vaso Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.